Sigma Planning »

Acurx Pharmaceuticals shares owned by Sigma Planning

Quarter-by-quarter ownership of Acurx Pharmaceuticals (ACXP) shares owned by Sigma Planning from 13F filings

Historical chart of Sigma Planning investment in Acurx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acurx Pharmaceuticals held by Sigma Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acurx Pharmaceuticals by Sigma Planning

Quarter filed Position value Share count Share price at filing
2023-12-31 $38k 10k 3.83

More positions owned by Sigma Planning

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Ishares Tr Core Div Grwth (DGRO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Ishares Tr S&p 500 Grwt Etf (IVW)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Iboxx Inv Cp Etf (LQD)
First Tr Exchng Traded Fd Vi Ft Cboe Eqty Bfr (FDEC)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Abbvie (ABBV)

View all positions for Sigma Planning

Top funds holding Acurx Pharmaceuticals

Vanguard Group
Prospect Financial Services
Advisor Group Holdings
Citadel Advisors
TD Waterhouse Canada
Nbc Securities
Tocqueville Asset Management
Simplex Trading
Sigma Planning
Cambridge Investment Research Advisors
Semmax Financial Advisors
Cornerstone Planning Group
Cutler
Advisory Services Network
Jpmorgan Chase & Co

View all funds holding Acurx Pharmaceuticals